- Home
- CTSO vs DHAI Comparison
CTSO vs DHAI Comparison
Compare CTSO & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- DHAI
- Stock Information
- Founded
- CTSO 1997
- DHAI 2007
- Country
- CTSO United States
- DHAI United States
- Employees
- CTSO N/A
- DHAI N/A
- Industry
- CTSO Medical/Dental Instruments
- DHAI
- Sector
- CTSO Health Care
- DHAI
- Exchange
- CTSO Nasdaq
- DHAI NYSE
- Market Cap
- CTSO 73.5M
- DHAI 85.1M
- IPO Year
- CTSO N/A
- DHAI N/A
- Fundamental
- Price
- CTSO $1.19
- DHAI $1.61
- Analyst Decision
- CTSO Strong Buy
- DHAI
- Analyst Count
- CTSO 3
- DHAI 0
- Target Price
- CTSO $4.67
- DHAI N/A
- AVG Volume (30 Days)
- CTSO 118.0K
- DHAI 22.7K
- Earning Date
- CTSO 11-07-2024
- DHAI 08-19-2024
- Dividend Yield
- CTSO N/A
- DHAI N/A
- EPS Growth
- CTSO N/A
- DHAI N/A
- EPS
- CTSO N/A
- DHAI N/A
- Revenue
- CTSO $37,159,990.00
- DHAI $67,615,000.00
- Revenue This Year
- CTSO $11.14
- DHAI N/A
- Revenue Next Year
- CTSO $17.07
- DHAI N/A
- P/E Ratio
- CTSO N/A
- DHAI N/A
- Revenue Growth
- CTSO 2.17
- DHAI 14.15
- 52 Week Low
- CTSO $0.70
- DHAI $0.72
- 52 Week High
- CTSO $2.15
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- CTSO 45.86
- DHAI 29.50
- Support Level
- CTSO $1.26
- DHAI $1.79
- Resistance Level
- CTSO $1.59
- DHAI $1.93
- Average True Range (ATR)
- CTSO 0.16
- DHAI 0.15
- MACD
- CTSO -0.03
- DHAI -0.04
- Stochastic Oscillator
- CTSO 14.89
- DHAI 6.45
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.